CMS opens temporary Medicare GLP-1 bridge program with $50 monthly co-pay

CMS has launched its temporary GLP-1 Bridge program for weight-loss drugs like Wegovy and Zepbound. This pilot offers Medicare beneficiaries access at a $50 monthly co-pay, a significant discount from typical out-of-pocket costs. The bridge program is designed to cover beneficiaries until broader coverage decisions are finalized. Practices should prepare for patient inquiries about coverage and prescribing requirements. Verify patient eligibility through the standard Medicare Part D channels and ensure documentation supports medical necessity for obesity treatment, as standard coverage criteria still apply. Monitor CMS communications for the program's official start date and operational details.